Stay updated on Phase II Anti-PD1 Epigenetic Therapy Clinical Trial

Sign up to get notified when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for a completed Phase II study of epigenetic therapy and nivolumab in metastatic non-small cell lung cancer is available, with study details, participant criteria, treatment arms, outcome measures, and study documents.
    Difference
    68%
    Check dated 2026-11-08T04:44:58.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0; the study page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T01:51:06.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition, including a notice that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T01:49:30.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T01:39:16.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer’s site revision number changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T02:04:10.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The study details page now displays a 403 Forbidden error, blocking access to the content.
    Difference
    0.5%
    Check dated 2026-09-27T01:50:51.000Z thumbnail image

Stay in the know with updates to Phase II Anti-PD1 Epigenetic Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.